Home › Interstitial Lung Diseases › North Carolina › Greensboro
Interstitial Lung Diseases clinical trials in Greensboro, NC
4 studies for Interstitial Lung Diseases are looking for participants at sites in and around Greensboro (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Greensboro
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Pulmonix, LLC, Greensboro
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Pulmonix LLC, Greensboro
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- PulmonIx LLC, Greensboro
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Charleston, SC13 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Dallas, TX9 studies
- Salt Lake City, UT9 studies
Other studies in Greensboro
- Overweight12 studies
- Obesity12 studies
- Type 2 Diabetes6 studies
- Heart Failure6 studies
- Breast Cancer5 studies
- Cardiovascular Disease5 studies
- HIV4 studies
- Stroke4 studies
- Heart Attack4 studies
- Lung Cancer3 studies
- Idiopathic Pulmonary Fibrosis3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.